Trial NCT04040621

View at ClinicalTrials.gov 
Org. Study IDs: C3591025
Secondary IDs: 2018-002841-12 EMBA

Last trial update was posted on 2022-09-09

MeSH Interventions

Avibactam Avibactam, ceftazidime drug combination Ceftazidime

MeSH Conditions

Healthcare-Associated Pneumonia Pneumonia

Other Conditions

Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia

Stopping Reasons

Following regulatory consultation, the Sponsor has decided to terminate the study and analyze the current dataset. The decision to terminate was solely based on a business decision, not due to safety concerns.

Limitations And Caveats

Only 4 participants were enrolled in this study. Outcome measures and AE data were not reported by cohort as planned in the protocol because doing so would risk re-dentification of the individual participants.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID